Volume 7 Issue 177
Published - 14:00 UTC 08:00 EST 26-Jun-2005 
Next Update - 14:00 UTC 08:00 EST 27-Jun-2005

Editor: Susan K. Boyer, RN
Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Politics and medicine don't mix: Ban of Medicare and Medicaid reimbursements for ED hurts prostate cancer patients

Lumping thousands of victims of crippling diseases in with those who abuse the system, Congress passed a ban of Medicare and Medicaid reimbursements for erectile dysfunction drugs today. more  

JDRF-funded european researchers find drug that preserves beta cell function in type 1 diabetes patients

The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable funder of research into type 1 diabetes and its complications, announced today that JDRF-funded researchers in Europe have shown that short-term treatment with an anti-CD3 antibody (ChAglyCD3) can preserve residual beta cell function and decreases the insulin need for at least 18 months in people with recent-onset type 1 diabetes. This finding, reported in the June 23 issue of the New England Journal of Medicine, represents an important step towards finding ways to prevent and stop type 1 diabetes by altering the clinical course of the disease. more

'Zomig' nasal spray provides relief in adolescent migraine

New clinical trial data presented today at the 47th American Headache Society Annual Scientific meeting shows that zolmitriptan ('Zomig') 5 mg nasal spray is highly effective and well tolerated in the acute treatment of adolescent migraine. more  

Short-term administration with novel drug candidate significantly reduces insulin need in newly diagnosed type 1 diabetics

A study published in the June 23 issue of the New England Journal of Medicine demonstrates that in patients with type 1 diabetes, a six day course of therapy with TRX4 (ChAglyCD3) preserves the function of insulin-producing beta cells in the pancreas and reduces the amount of administered insulin needed to control blood glucose levels for at least 18 months. more

Antibiotic treatment not necessary for majority of children with conjunctivitis 

Some doctors have claimed that people with naturally red hair may need more anesthetic than others. It turns out they may be right. more

Possible treatment changes for asthma 

Some adults with mild persistent asthma may be able to control their asthma by taking corticosteroids only when needed, according to a new study supported by NIH. Those who took corticosteroids when their symptoms arose had about the same number of severe asthma flare-ups as those taking daily, long-term control medications. This finding needs to be confirmed in a larger study, but it suggests that some patients may be able to safely avoid the expense and inconvenience of daily medication. more

Gene changes linked to deficient immune suppression in MS

Oregon Health & Science University researchers have measured genetic changes reflecting a drop in the body's ability to suppress inflammatory cells that attack nerve fibers and promote progression of multiple sclerosis. more

 

When Congress and medicine mix, patients frequently suffer.